And besides, he was already talking. “First of all, I’m FBI, and yes, I’m fully qualified as a field agent, but my focus is on white-collar crime,” he said. “Forensic accounting. That’s why they brought me in here to try to autopsy the Pharmadene books while I administer the shutdown process. Most of what I found is totally aboveboard; like all major corporations, they had to have yearly audits from reputable vendors. But what happened this past year was completely out of the ordinary. I’m sure the plan was that by the time the audit requirement came around, they’d control a large enough chunk of the important people”—given finger quotes—“that they wouldn’t be at any risk of discovery. All that should have come to a stop when Irene Harte and her contingent of corporate rebels was taken out, but the thing is, some of these suspicious financial activities haven’t stopped, and I’m hitting a stone wall. If I take it through official channels, my fear is that word will leak before we can really nail down what’s going on. So. You’re our…black ops team, I suppose. For lack of a better term.”
“You know that it’s a condition of my continued freedom to do whatever work the FBI wants me to do,” Bryn said. “It’s not as if I really have a choice.”
“I know about your agreement. And I also know that Pharmadene continues to dispense, out of the refrigerated stockpiles, a limited quantity of Returné to selected individuals. You’re one of them.”
And, in fact, she wasn’t using her store directly; she gave it to Manny Glickman, who tinkered with the formula, stripping out all the “extras” that Pharmadene’s genetic engineering had put into it. Those extras would have allowed Pharmadene’s in-the-know executives—those that had survived, anyway—to control her in a real and immediate way, and it was something she never wanted to experience again. Certainly the government knew of the built-in Protocols by now. She could never take that chance.
But she merely said, “Yes.”
Zaragosa shook his head. “I know this sucks, Ms. Davis, and I wish there was a better answer for it, but please understand, I believe that the people receiving these payments are probably involved in the illegal manufacture and sale of Returné. Neither of us wants to see that continue. It’s a drug that has no real upside, not for anyone.”
“What about the cancer cure it was intended to be?”
“We’re working it back to that, but the revival drug itself…we’ll never manufacture it again. It’s just too dangerous. The formula has been wiped completely from servers, backups, everywhere.”
She really doubted that, although Zaragosa probably believed it. No way was the government going to just delete that information; there were secret backups, secret labs probably even now working on the formulas. Dangerous things didn’t get incinerated; they got archived. Like smallpox. Just in case.
“What do you have so far on tracing the payments?” she asked. Zaragosa pulled out a folder from the stack and thumbed through it, then handed it over to her with one page pulled out to the front. It looked like a flowchart, but it was incredibly complex—the payments went to a shell company, split, flowed a dozen directions, all of which bounced to other accounts all around the world. “You do realize that my skills aren’t exactly accounting-related, don’t you?”
For answer, he produced another, handwritten sheet of paper. She somehow had no doubt that he’d written it himself. On it was an address in Los Angeles and a short message: CAN’T PUT THIS ON RECORD. WE ARE BEING MONITORED 24/7, EVERYWHERE.
She glanced up at his face, and saw the intensity there. He wasn’t kidding. He didn’t trust his own people.
“As you can see,” Zaragosa said, “all I can tell you is that although the payments look legitimate, they are definitely suspicious just from the care that’s been taken to reroute and conceal them. I would start with the apparent front company, if I were you. But please, be careful. I can’t guarantee that this won’t be dangerous.”
He meant that; she could tell. She nodded, closed the folder, and tucked it under her arm. “I understand,” Bryn said. She stood up and offered her hand. “I’ll call you when I have something.”
“My card,” Zaragosa said, and reached over to pull one from a stack—except the one he pulled out had writing on the back, she could feel that without even turning it over. She nodded, tapped it once, and slid it into her jacket pocket. “Call anytime.”
“Am I free to go now?”
“Of course. Jeremy will walk you out. I’m sorry I can’t go myself, but I’m scheduled for a conference call in just a few moments. My thanks for being so understanding of our dilemma.”
She nodded and the assistant’s arrival at the door derailed any possible reply she might have come up with. There was a lot going on here, and a lot she couldn’t understand…but she trusted Zaragosa, maybe unreasonably so. If what he had scribbled out was true, there was a grave problem within Pharmadene—a crippling problem for the FBI that they probably didn’t even trust their own technical people to investigate. There were cameras everywhere in this building, and it wasn’t hard, if you were inside the system, to keep track of everyone’s computer activity, read messages, monitor digital phone calls. There was no privacy, especially if they had people bugged at home, too.
Pharmadene had always had oppressive, intrusive security, but it ought to have been turned off by now, or at least be under the FBI’s control.
That it wasn’t was a sign that things were still very, very dangerous.
So of course, they throw me right in the middle of it, Bryn thought. She slipped Zaragosa’s card in her pocket. The temptation to read what he’d put on the back of it was very, very strong, but she didn’t dare. High-definition cameras everywhere. She’d be sharing the contents of the note with anyone who cared to look.
McCallister wasn’t going to be any happier about all this intrigue than she was. That was somehow a little heartening.
Jeremy was about as chatty as Ms. Harris had been. He had a nicer suit than his boss, and there was something about his subtle, expensive aftershave that irritated Bryn; he seemed more like Old Guard than New FBI. She wanted out of the elevator, out of the building, out of the clinging slime of Pharmadene, but she had to patiently wait through the long drop to the ground floor, sign out, turn in her badge, fingerprint out, get in her car, fingerprint out again at the gate, before she finally achieved some kind of freedom. Nobody searched the folder during her exit interview, which she found curious until she saw the stamp on the outside. It had Zaragosa’s personal signature on it, and it said EYES ONLY, with her name listed.
She drove off the Pharmadene campus and five miles along the winding road until she felt it was safe, and then turned off into a large park and made sure to pull into the shade of a big, spreading tree. The place was mostly deserted. She opened the windows, turned off the engine, and first checked the folder over very, very carefully—not the contents, but the structure of the paper.
That was how she found the device, tiny as it was, embedded in the thick folder itself. It was certainly a tracker; it might do more than that, too. She couldn’t take the chance. She separated the contents of the file from the folder, then looked through each page, holding it up to the light for any telltale shadows. All she found were standard watermarks.
Bryn took the folder to the nearest recycling station and added it to a bin destined for shredding. Then she turned his business card over and read the back of it.
It read: Do not trust Riley Block.
The address he’d written out in longhand she kept in her pocket, along with the business card—which she also checked for a tracker. The rest of the paperwork would go into her safe at the office until she had time later to study the thick, dense information.